A clinically relevant gene signature in triple negative and basal-like breast cancer - Wikidata - wikimedia - TriplyDB

A clinically relevant gene signature in triple negative and basal-like breast cancer

A clinically relevant gene signature in triple negative and basal-like breast cancer

http://www.wikidata.org/entity/Q35683578

about

The Interactions of Obesity, Inflammation and Insulin Resistance in Breast Cancer Antiangiogenesis therapy for breast cancer: an update and perspectives from clinical trials Genomic profiling in triple-negative breast cancer Why the stroma matters in breast cancer: insights into breast cancer patient outcomes through the examination of stromal biomarkers Biological network-driven gene selection identifies a stromal immune module as a key determinant of triple-negative breast carcinoma prognosis.A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition Breast cancer subtypes and previously established genetic risk factors: a bayesian approach Molecular phenotypes in triple negative breast cancer from African American patients suggest targets for therapy Identification of Personalized Chemoresistance Genes in Subtypes of Basal-Like Breast Cancer Based on Functional Differences Using Pathway Analysis Association of Protein Translation and Extracellular Matrix Gene Sets with Breast Cancer Metastasis: Findings Uncovered on Analysis of Multiple Publicly Available Datasets Using Individual Patient Data Approach Breast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.Immune DNA signature of T-cell infiltration in breast tumor exomes.Double-edged role of G protein-coupled estrogen receptor 1 in breast cancer prognosis: an analysis of 167 breast cancer samples and online data sets Increased macroH2A1.1 expression correlates with poor survival of triple-negative breast cancer patients Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer.Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease.A New Gene Expression Signature for Triple Negative Breast Cancer Using Frozen Fresh Tissue before Neoadjuvant Chemotherapy.Expression of RUNX1 correlates with poor patient prognosis in triple negative breast cancer Ferritin heavy chain in triple negative breast cancer: a favorable prognostic marker that relates to a cluster of differentiation 8 positive (CD8+) effector T-cell response.Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes.Prognostic B-cell signatures using mRNA-seq in patients with subtype-specific breast and ovarian cancer.XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway.Hallmarks of triple negative breast cancer emerging at last?Preliminary characterization of IL32 in basal-like/triple negative compared to other types of breast cell lines and tissues.Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures.Novel role of Engrailed 1 as a prosurvival transcription factor in basal-like breast cancer and engineering of interference peptides block its oncogenic function.Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse Interleukin-8 in breast cancer progression.Predicting response and survival in chemotherapy-treated triple-negative breast cancer.Identification of common prognostic gene expression signatures with biological meanings from microarray gene expression datasets.Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis.Innate immunity pathways and breast cancer Risk in African American and European-American women in the Women's Circle of Health Study (WCHS).Proline-rich protein 11 regulates epithelial-to-mesenchymal transition to promote breast cancer cell invasion.Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer.Serial analysis of 38 proteins during the progression of human breast tumor in mice using an antibody colocalization microarray.A mammary stem cell population identified and characterized in late embryogenesis reveals similarities to human breast cancer.Wild-Type N-Ras, Overexpressed in Basal-like Breast Cancer, Promotes Tumor Formation by Inducing IL-8 Secretion via JAK2 Activation.Control of dataset bias in combined Affymetrix cohorts of triple negative breast cancer Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer An "elite hacker": breast tumors exploit the normal microenvironment program to instruct their progression and biological diversity.

P2860

Q26777775-A8CB4454-D9D1-45FC-A84F-8FCEB3D90B9B Q26822432-5D3AA373-9765-478F-A9E2-B2D3440DD27D Q27015775-C7BB64B5-FA63-4E8D-8689-317BCD56CA61 Q27023385-EB5D34D3-9CBB-4359-95DE-99B2CF53B59E Q27311085-6AEF06D9-8D57-48B6-98F2-31D49DA6CBAE Q28305715-FE7C7D66-9FA3-4D2D-9745-31D5B438C66B Q28397311-AD01A799-D049-4F12-8D1B-9482C8B19D93 Q28535227-272EB873-5864-43DD-A2C3-4C0B3A403A9E Q28545978-19082837-9CE1-49A0-9244-60537692D998 Q30000323-8AD3BF68-26D0-4AFB-B4E9-F0D2851631B2 Q30245184-241A6DCA-0DD1-4A3D-ABC1-FE8B41FCC390 Q30377226-F440C17D-E1A0-4F6E-89C1-28197B823154 Q31141334-DBCEE5E5-A628-455F-9FBC-14369D61EC8F Q33727273-2145A76B-305A-47DE-9FE6-A8DA8308A12A Q33739233-C0B59CB0-FA43-437F-B320-3920F99210D6 Q33769821-1E1EE67A-ABC5-47C7-9EDD-75126FC8C75D Q33793872-E523679F-2EF0-401E-8D47-D4D5338F6447 Q33812500-2D256B7A-880B-4588-B069-553E805D48EE Q33850657-6F4929BB-883B-4363-A3E1-4D5B875D8997 Q33874621-A8EEEA9A-4217-4A14-B283-D4438DB046DB Q33916814-191B3724-427B-4B6A-BD85-D492DF09E48F Q33926690-7818565D-4258-4E62-991D-F63EE5BCC023 Q34008421-CB43C65D-F1E9-4D0F-A20C-57818388C4F2 Q34042748-380E220E-E78C-4984-AFE3-A73B6F320B4B Q34119025-44221306-3016-4187-9DED-46E314B8B192 Q34285190-1DA89032-4DE4-493D-A8EC-20808275FC6E Q34327636-0040F40B-5A38-4209-B98B-6EC3A01E4FC4 Q34346108-E15936FC-BFC6-49B0-BFF7-F22491CC9143 Q34354538-21655A8C-608A-458D-A52A-A9C8693D2082 Q34430310-F9DB08CB-4A95-4C61-AF11-82FFB5CEB7A4 Q34547261-B4C74B94-BDBE-427D-B01F-B0EF8C297047 Q34977106-F4AF37F3-6E85-40A8-AB79-F86AD7FF9976 Q35038709-E036862E-7A25-4F26-897D-33BAA92F268E Q35185688-D3D1AE97-0C28-402A-8E94-1005E389567D Q35325472-0ECCF5BE-C4B2-4F11-A0D1-533C7D19C08F Q35750639-0CAE20AD-4AE4-4365-95BB-DFCA976A8D7D Q35883071-404B3EBE-6D56-4613-8564-A3AA283D54C4 Q35951787-7A82D6E7-4EF5-408F-895F-6BBC763D7E69 Q36030226-A7F291B2-76CD-4CDC-8632-641D3453B017 Q36187733-425DA37C-5F0D-45E6-84EB-BF5EB6EB82EA

P2860

A clinically relevant gene signature in triple negative and basal-like breast cancer

http://www.wikidata.org/entity/Q35683578

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

A clinically relevant gene signature in triple negative and basal-like breast cancer

@ast

A clinically relevant gene signature in triple negative and basal-like breast cancer

@en

type

label

A clinically relevant gene signature in triple negative and basal-like breast cancer

@ast

A clinically relevant gene signature in triple negative and basal-like breast cancer

@en

prefLabel

A clinically relevant gene signature in triple negative and basal-like breast cancer

@ast

A clinically relevant gene signature in triple negative and basal-like breast cancer

@en

P1433

Q35683578-1918AD49-36E1-47A0-87F7-4BFA7207F392

P1476

Q35683578-802EEC4D-F3AB-43B0-A1CE-D3F6199A3DB1

P2093

Q35683578-172763F0-D2D4-4A26-92BB-F32BFFA5618F

Q35683578-18F9387C-D747-4F30-8FAC-DBA9AF838C9C

Q35683578-3B322192-D07C-4E74-B3E4-BFC5F55958AD

Q35683578-3FC52D78-4707-4211-9B9A-6A0FE9635722

Q35683578-58F54023-AD30-4A36-9B0A-63EA6E56B2BC

Q35683578-69C49C9C-2109-4ED6-836C-A5CD538B241F

Q35683578-7F72A5D3-9D6B-4D73-8AC4-A7843A78AC01

Q35683578-A237C5A2-A666-4F76-80B1-E721B37FF452

Q35683578-C0F6255B-0EAB-49C8-9EF6-BAB2BD9C4C07

Q35683578-C3378C37-AE51-4189-AD8C-703B301B710A

P2860

Q35683578-05F8FADC-FC85-4206-AC7D-D277BA16DFD9

Q35683578-08DA9FFE-CB55-4F03-9667-A313361AE11F

Q35683578-0C435466-E9B2-4209-99FD-EF5F2B9C1283

Q35683578-0FD0B4F8-6F4F-4752-80BA-57F097FCD1CA

Q35683578-19310400-51C7-4F4E-8705-E20E6F66AF39

Q35683578-1A7AE669-D457-4EE8-959B-02E1D083A946

Q35683578-1D54CB22-B486-485E-B4D5-2636F3FB9E95

Q35683578-1DB77F98-06A2-4F6A-BEF1-7B73C446E213

Q35683578-1F97DE65-D43A-41E8-99B2-118C78E5B1CD

Q35683578-26617557-AF78-4B95-8901-0C9656E22D12

P2888

Q35683578-7A31BDBF-CF66-4435-A10E-6A63965C855E

P304

Q35683578-77312339-AF71-4B53-A501-427249895D8A

P31

Q35683578-31EE12B4-AE08-403E-86BE-B00C8F2C425F

P356

Q35683578-4A93F658-4E71-4DC2-9D7B-80574FA37FB0

P433

Q35683578-BB69D43A-3D5F-4AD5-A9A0-42F093BAD7B0

P478

Q35683578-2BA49CE7-55E4-4316-B0F4-AB2CE5454381

P50

Q35683578-42BABA24-B102-48D5-AE94-C82422BFFB4A

P577

Q35683578-F7AD9FEE-FB80-42EC-8EB8-087D5881792F

P5875

Q35683578-7B74027E-F2CA-4938-89AC-6C63C7BC70D5

P6179

Q35683578-3FCB06DF-30F0-4586-A126-C18E982BCEE1

P698

Q35683578-D49284B1-6B9D-4840-96A7-7B3463ADF702

P932

Q35683578-34589715-7264-4388-BE7C-FCBBB2BEB88B

P356

P1433

Breast Cancer Research

P1476

A clinically relevant gene signature in triple negative and basal-like breast cancer

@en

P2093

Achim Rody

http://www.w3.org/2001/XMLSchema#string

Andre Ahr

http://www.w3.org/2001/XMLSchema#string

Christine Solbach

http://www.w3.org/2001/XMLSchema#string

Cornelia Liedtke

http://www.w3.org/2001/XMLSchema#string

Dirk Metzler

http://www.w3.org/2001/XMLSchema#string

Eugen Ruckhaeberle

http://www.w3.org/2001/XMLSchema#string

Lajos Pusztai

http://www.w3.org/2001/XMLSchema#string

Lars Hanker

http://www.w3.org/2001/XMLSchema#string

Manfred Kaufmann

http://www.w3.org/2001/XMLSchema#string

Marcus Schmidt

http://www.w3.org/2001/XMLSchema#string

P2860

CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts

A gene-expression signature as a predictor of survival in breast cancer

Molecular portraits of human breast tumours

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

''R"--project for statistical computing

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

P2888

P304

R97

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR3035

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51705209

http://www.w3.org/2001/XMLSchema#string

P6179

1038425218

http://www.w3.org/2001/XMLSchema#string

P698

21978456

http://www.w3.org/2001/XMLSchema#string

P932

3262210

http://www.w3.org/2001/XMLSchema#string